A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Six new drugs, including a treatment for patients with advanced breast cancer, have been approved for use by the NHS in ...

Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

Keytruda is already approved by the FDA as a first-line therapy for PD-L1-positive metastatic cervical cancer in combination with chemo, with or without bevacizumab, and as a second-line therapy ...

as a monotherapy for the treatment of adult patients with second-line recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy. The approval means ...

If confirmed on larger case studies, the results of this study suggest that samples for Tg/CT mRNA and Tg protein measurements from CLN suspicious for metastatic thyroid cancer should be always ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Metastatic cervical cancer is treated with systemic therapy (chemotherapy, targeted therapy or immunotherapy). Outcomes of disease vary as per the nature of the healthcare facilities. The outcome ...

On 4 February 2025, the global community observed World Cancer Day, a time to raise awareness about cancer prevention, ...

Regeneron UK Limited has announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo (cemiplimab) for use on ...